Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017

Michael Yee Initiated (VRTX) at Buy and Held Target at $175 on, Sep 15th, 2017

Michael Yee of RBC Capital, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $175 on, Sep 15th, 2017.

Michael has made no other calls on VRTX in the last 4 months.



There are 8 other peers that have a rating on VRTX. Out of the 8 peers that are also analyzing VRTX, 0 agree with Michael's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Michael


  • Christopher Raymond of "Raymond James" Upgraded from Hold to Buy on, Wednesday, July 19th, 2017
  • Debjit Chattopadhyay of "Janney Montgomery Scott" Upgraded from Hold to Strong Buy on, Wednesday, July 19th, 2017
  • Geoff Meacham of "Barclays" Upgraded from Hold to Buy on, Wednesday, July 19th, 2017
  • Phil Nadeau of "Cowen & Co." Upgraded from Hold to Buy on, Wednesday, July 19th, 2017
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Wednesday, July 19th, 2017
  • Biren Amin of "Jefferies" Initiated at Strong Buy and Held Target at $155 on, Tuesday, July 11th, 2017
  • Alan Carr of "Needham" Upgraded from Hold to Strong Buy on, Friday, June 23rd, 2017
  • Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy on, Friday, June 2nd, 2017